MACK
Merrimack Pharmaceuticals, Inc.
MACK
MACK
Delisted
MACK was delisted on the 17th of May, 2024.
78 hedge funds and large institutions have $74M invested in Merrimack Pharmaceuticals, Inc. in 2017 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
28% less call options, than puts
Call options by funds: $187K | Put options by funds: $260K
Holders
78
Holding in Top 10
–
Calls
$187K
Puts
$260K
Top Buyers
| 1 | +$1.8M | |
| 2 | +$1.44M | |
| 3 | +$1.21M | |
| 4 |
Russell Investments Group
London,
United Kingdom
|
+$982K |
| 5 |
RCMNY
Rubric Capital Management (New York)
New York
|
+$742K |
Top Sellers
| 1 | -$2.26M | |
| 2 | -$720K | |
| 3 | -$635K | |
| 4 |
QIM
Quantitative Investment Management
Charlottesville,
Virginia
|
-$623K |
| 5 |
Swiss National Bank
Zurich,
Switzerland
|
-$294K |